Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma.

Song WangXueyou MaYufan YingJiazhu SunZitong YangJiangfeng LiKe JinXiao WangBo XieXiangyi ZhengBen LiuLiping Xie

Published in: Cancer cell international (2021)

ARNTL2 is an independent adverse predictor of ccRCC patient survival. High expression level of ARNTL2 is associated with immune infiltration, and may be a novel therapeutic target in ccRCC.

Keyphrases

poor prognosis
free survival
cell proliferation
case report
long non coding rna
emergency department